Qube Research & Technologies (QRT)
BIO icon

Qube Research & Technologies (QRT)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-72,770
Closed -$25.2M – 3832
2024
Q1 		$25.2M Sell
72,770
-97,148
-57% -$31.9M 0.04% 488
2023
Q4 		$54.9M Buy
169,918
+168,970
+17,824% +$53M 0.11% 240
2023
Q3 		$340K Buy
+948
New +$366K ﹤0.01% 2190
2023
Q1 		– Sell
-8,532
Closed -$3.59M – 2551
2022
Q4 		$3.59M Sell
8,532
-7,407
-46% -$2.99M 0.02% 754
2022
Q3 		$6.65M Buy
15,939
+5,058
+46% +$2.52M 0.04% 528
2022
Q2 		$5.39M Sell
10,881
-17,640
-62% -$9.19M 0.04% 480
2022
Q1 		$16.1M Sell
28,521
-1,283
-4% -$773K 0.14% 195
2021
Q4 		$22.5M Buy
29,804
+6,194
+26% +$4.64M 0.17% 124
2021
Q3 		$17.6M Buy
23,610
+23,121
+4,728% +$17.3M 0.22% 100
2021
Q2 		$315K Sell
489
-10,915
-96% -$6.64M ﹤0.01% 1549
2021
Q1 		$6.51M Buy
+11,404
New +$6.75M 0.1% 245
2020
Q4 		– Sell
-9,585
Closed -$4.94M – 1816
2020
Q3 		$4.94M Sell
9,585
-18,473
-66% -$9.36M 0.07% 358
2020
Q2 		$12.7M Buy
28,058
+27,445
+4,477% +$12.1M 0.19% 122
2020
Q1 		$215K Buy
613
+35
+6% +$12.9K 0.01% 847
2019
Q4 		$214K Buy
+578
New +$204K 0.01% 1362
2019
Q3 		– Sell
-738
Closed -$231K – 261
2019
Q2 		$231K Buy
+738
New +$221K 0.06% 323
2018
Q4 		– Sell
-763
Closed -$239K – 360
2018
Q3 		$239K Buy
763
+624
+449% +$194K 0.03% 440
2018
Q2 		$40K Buy
+139
New +$38.4K 0.03% 583

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIO Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2024, closing a stake of 72,770 shares — an estimated $25.2M sold.

Qube Research & Technologies (QRT) first reported a position in BIO in Q2 2018 and held it in 18 quarters. The position peaked at $54.9M in Q4 2023. 440 funds tracked by Wall St. Rank hold BIO as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Bio-Rad Laboratories Class A position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 72,770 Bio-Rad Laboratories Class A shares in Q2 2024, an estimated $25.2M.
  • Qube Research & Technologies (QRT) first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 18 quarters.
  • Qube Research & Technologies (QRT)'s Bio-Rad Laboratories Class A position peaked at $54.9M in Q4 2023.
  • 440 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.